Contact Us

Joshua Maniscalco Recognized for Excellence in Psychiatry

Dr. Maniscalco specializes in treatment for patients with a variety of mental health conditions including anxiety disorders, OCD, ADHD and depression
    AUSTIN, TX, August 03, 2016 /24-7PressRelease/ -- Dr. Joshua Maniscalco, Doctor at Westlake Psychiatry in Austin, Texas has been recognized for leadership and excellence in the field of psychiatry, and was recently recognized as a Top 100 Doctor in the state of Texas.

Dr. Maniscalco has dedicated his career to helping children, adolescents and adults, and is an expert in the treatment of ADHD, anxiety, OCD, and mood disorders. Over the past decade, he has received numerous awards for exemplary work: he was named "Patient's Choice" in 2011, 2012, 2013, 2014, and was selected as a "Most Compassionate Doctor." Dr. Maniscalco has worked with some of the field's leading experts in the field of psychiatry and has extensive experience studying at some of the world's foremost academic institutions including UCLA School of Medicine, Harvard Medical School and Yale University.

Dr. Maniscalco graduated with honors from U.T. Austin and earned his MD at Texas A&M University. He completed his specialty training in psychiatry at the NYU School of Medicine. Dr. Maniscalco requested that his Worldwide Registry recognition be used to thank some of his mentors, including Dr. Bill Wirshing at The UCLA School of Medicine, Dr. Robert Waldinger and Dr. John Ratey at Harvard Medical School, Dr. James Leckman, Donald Cohen and Andres Martin at Yale University Child Study Center, Dr. Michael Dulchin at NYU School of Medicine, and Dr. Edward Hallowell.

# # #

Read more Press Releases from Ellen Campbell:

Comment on this story...

Share This Story

Email this Story

Contact Information

Ellen Campbell
Worldwide Registry

Syosset, NY
United States
Voice: (516) 393-0440
E-Mail: Email Us Here

Like This Story?

I like it! 0


If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release Newswire. We are unable to assist you with any information regarding this release. 24-7 Press Release Newswire disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.